Vertex Pharmaceuticals Inc (VRTX) Insider Trading
- $12,939,410.00
- $1,027,201,493.43
- March 10, 2025
- Joshua S Boger
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| May 2, 2023 | Director | 580 | $348.28 | Sell | $202,002.40 | |
| May 2, 2023 | EVP | 1,622 | $350.66 | Sell | $568,770.52 | |
| April 27, 2023 | CEO | 3,317 | $339.08 | Sell | $1,124,728.36 | |
| April 12, 2023 | EVP | 7,567 | $326.70 | Sell | $2,472,138.90 | |
| April 12, 2023 | Director | 21,300 | $326.73 | Sell | $6,959,349.00 | |
| April 4, 2023 | EVP | 522 | $315.81 | Sell | $164,852.82 | |
| March 24, 2023 | CFO | 1,768 | $305.38 | Sell | $539,911.84 | |
| March 17, 2023 | CFO | 2,000 | $296.39 | Sell | $592,780.00 | |
| March 16, 2023 | EVP | 2,746 | $300.59 | Sell | $825,420.14 | |
| March 13, 2023 | CFO | 2,666 | $293.83 | Sell | $783,350.78 | |
| March 10, 2023 | CFO | 2,088 | $289.61 | Sell | $604,705.68 | |
| Feb. 27, 2023 | CAO | 1,207 | $287.55 | Sell | $347,072.85 | |
| Feb. 27, 2023 | EVP | 354 | $287.48 | Sell | $101,767.92 | |
| Feb. 27, 2023 | COO | 5,034 | $287.47 | Sell | $1,447,123.98 | |
| Feb. 22, 2023 | COO | 2,401 | $294.33 | Sell | $706,686.33 | |
| Feb. 13, 2023 | COO | 4,887 | $298.92 | Sell | $1,460,822.04 | |
| Feb. 13, 2023 | EVP | 275 | $298.99 | Sell | $82,222.25 | |
| Feb. 6, 2023 | EVP | 1,304 | $306.00 | Sell | $399,024.00 | |
| Jan. 30, 2023 | Director | 2,700 | $320.52 | Sell | $865,404.00 | |
| Jan. 27, 2023 | Director | 1,429 | $322.03 | Sell | $460,180.87 | |
| Jan. 25, 2023 | Director | 4,000 | $313.96 | Sell | $1,255,840.00 | |
| Jan. 25, 2023 | CEO | 10,000 | $315.05 | Sell | $3,150,500.00 | |
| Jan. 23, 2023 | Director | 2,129 | $312.02 | Sell | $664,290.58 | |
| Jan. 18, 2023 | Director | 442 | $312.17 | Sell | $137,979.14 | |
| Nov. 7, 2022 | EVP | 1,303 | $303.04 | Sell | $394,861.12 | |
| Oct. 24, 2022 | Director | 621 | $310.00 | Sell | $192,510.00 | |
| Oct. 18, 2022 | EVP | 1,791 | $300.31 | Sell | $537,855.21 | |
| Aug. 15, 2022 | SVP | 3,747 | $303.90 | Sell | $1,138,713.30 | |
| Aug. 15, 2022 | CEO | 11,689 | $305.06 | Sell | $3,565,846.34 | |
| Aug. 15, 2022 | COO | 22,173 | $303.93 | Sell | $6,739,039.89 | |
| Aug. 9, 2022 | COO | 5,690 | $300.67 | Sell | $1,710,812.30 | |
| Aug. 9, 2022 | SVP | 946 | $300.00 | Sell | $283,800.00 | |
| Aug. 9, 2022 | EVP | 1,400 | $298.97 | Sell | $418,558.00 | |
| Aug. 8, 2022 | Director | 621 | $293.03 | Sell | $181,971.63 | |
| July 29, 2022 | Director | 621 | $278.77 | Sell | $173,116.17 | |
| July 25, 2022 | Chairman | 132,079 | $281.38 | Sell | $37,164,389.02 | |
| July 19, 2022 | EVP | 17,865 | $288.65 | Sell | $5,156,732.25 | |
| June 24, 2022 | CEO | 11,689 | $291.30 | Sell | $3,405,005.70 | |
| May 4, 2022 | EVP | 36 | $275.09 | Sell | $9,903.24 | |
| May 2, 2022 | EVP | 320 | $259.16 | Sell | $82,931.20 | |
| May 2, 2022 | Director | 737 | $258.94 | Sell | $190,838.78 | |
| May 2, 2022 | CFO | 343 | $258.83 | Sell | $88,778.69 | |
| May 2, 2022 | COO | 306 | $263.98 | Sell | $80,777.88 | |
| April 29, 2022 | SVP | 120 | $275.41 | Sell | $33,049.20 | |
| April 25, 2022 | CAO | 327 | $269.55 | Sell | $88,142.85 | |
| April 18, 2022 | Director | 2,000 | $284.23 | Sell | $568,460.00 | |
| April 13, 2022 | Chairman | 15,789 | $289.04 | Sell | $4,563,652.56 | |
| April 13, 2022 | Director | 2,000 | $287.50 | Sell | $575,000.00 | |
| April 11, 2022 | Director | 2,000 | $280.30 | Sell | $560,600.00 | |
| April 7, 2022 | EVP | 561 | $276.18 | Sell | $154,936.98 |
Insiders are both buying and selling Vertex Pharmaceuticals Inc stock.
The insider traders at Vertex Pharmaceuticals Inc are: Joshua S Boger, Paul M Silva, Stuart A Arbuckle, Jeffrey M Leiden, Amit Sachdev, Michael Parini, Jeffrey Chodakewitz, David Altshuler, Joshua S. Boger, Yuchun Lee, Reshma Kewalramani, Sangeeta N Bhatia, Ourania Tatsis, Ian F Smith, Bastiano Sanna, Bruce I Sachs, Joshua Boger, Peter Mueller, Charles F Wagner Jr, Carmen Bozic, Margaret G Mcglynn, Bruce Sachs, Elaine Ullian, Stuart A. Arbuckle, Kristen Ambrose, Jeffrey Leiden, Joy Liu, Kenneth L Horton, Megan E Pace, Megan Pace, Wayne Joseph Riley, Paul Silva, Thomas Graney, Christiana Stamoulis, Kenneth Horton, Sangeeta N. Bhatia, Ian F. Smith, Paul M. Silva, Terrence C Kearney, Thomas Connolly, Jeffrey M. Leiden, William D Young, Jonathan Biller, Edward Morrow Atkinson III, and Lloyd Carney
The most active insider trader at Vertex Pharmaceuticals Inc is Joshua S Boger with 99 trades.
Jeffrey M Leiden has sold the most Vertex Pharmaceuticals Inc stock with a total value of $395,375,749.22.
Reshma Kewalramani has bought the most Vertex Pharmaceuticals Inc stock with a total value of $17,310,520.00.
The most recent insider trade for Vertex Pharmaceuticals Inc was on March 10, 2025.
The single biggest insider buy for Vertex Pharmaceuticals Inc was from Reshma Kewalramani with a total value of $7,677,010.00 on July 30, 2024.
The single biggest insider sell for Vertex Pharmaceuticals Inc was from Jeffrey M Leiden with a total value of $37,164,389.02 on July 25, 2022.